A recent analysis found that about 10% of RA patients taking tofacitinib do not follow recommended guidelines and more than half stop treatment by one year…
Statins & the Risk of RA
Statins have anti-inflammatory/immunomodulatory effects that may be useful in preventing rheumatoid arthritis (RA), but previous observational studies about the risk of RA with statin use yielded conflicting results. In this large population-based study, high-intensity statin treatment was associated with a 23% reduced risk of RA when compared with low-intensity statin treatment. This is the largest study on the association of statins with RA risk to date, and the first to assess the effect of relative statin strength…
Challenges Rheumatologists Will Face in 2017
Rheumatologists and rheumatology health professionals interested in knowing more about the major legislative and regulatory issues that may have an impact on their practice will want to attend the Legislative and Regulatory Update 2016 session at the upcoming ACR/ARHP Annual Meeting. On Tuesday, Nov. 15, from 7:30–8:30 a.m. in Room 140A, Will Harvey, MD, MSc,…
Rheumatologists Urged to Engage in Advocacy
“Doctors must be politically active or they will surrender the control of healthcare to others,” says Tim Hutchinson, former U.S. Senator from Arkansas (Republican), emphasizing the need for rheumatologists to become involved in advocacy given the particularly challenging environment caused by partisan polarization and gridlock in Washington—which is expected to continue regardless of the upcoming…
ACR Opposes DXA Reimbursement Cuts
The Centers for Medicare and Medicaid Services (CMS) plans to significantly reduce reimbursement for dual-energy X-ray absorptiometry (DXA),—used to measure bone density, diagnose osteoporosis and help prevent fractures—performed as a hospital outpatient service in the 2017 Hospital Outpatient Prospective Payment System (HOPPS). If finalized, by 2023 it will cut payment for the DXA testing by 37%….
Physicians Asked to Join AMA Efforts to Reduce Opioid Abuse
In 2014, the American College of Rheumatology (ACR) was one of 25 healthcare associations invited to participate in an initiative by the American Medical Association (AMA) to reduce the public health epidemic posed by the abuse of prescription opioids.1 The AMA initiative is based on the belief that physicians are professionally obligated to participate in…
SSRIs Act Centrally to Cause Bone Loss
In a recent study, investigators examined the effects of both the short- and long-term use of selective serotonin-reuptake inhibitors (SSRIs) on the development and loss of bone. The study results describe the mechanisms by which SSRIs, specifically fluoxetine, affect osteoclasts short term to increase bone mass, but also how the treatment may cause bone loss at six weeks in mice…
Can Nasal Tissue Be Used to Repair a Damaged Knee Joint?
(Reuters Health)—Doctors might one day be able to harvest cells from patients’ noses to produce cartilage that can be transplanted into damaged knee joints, a small experiment suggests. Because the experiment only included 10 adults who were followed for just two years, it’s impossible to say for sure whether this procedure would be safe or…
Hospitals May Face Bigger Penalties for Readmissions Than Deaths
(Reuters Health)—Medicare penalties are tied to fewer repeat hospitalizations for some common health problems, but a new study suggests current policy doesn’t encourage hospitals in the U.S. to focus on preventable deaths. Researchers examined nationwide data for both deaths and readmissions within 30 days of discharge for three common problems: heart failure, pneumonia and heart…
The Fight Against the Medicare Part B Demonstration Project
The ACR and 315 other organizations have publicly said savings would not be achieved by the demonstration project and that it will reduce access to care for patients…
- « Previous Page
- 1
- …
- 222
- 223
- 224
- 225
- 226
- …
- 309
- Next Page »